Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2.

doi:10.1006/viro.1999.0015

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2.

Virology - 25 Nov 1999

Aguirre A J, Robertson E S

Abstract excerpt

Epstein-Barr Virus (EBV) can infect and transform human B-lymphocytes and has been associated with numerous human malignancies. Two distinct types of EBV have been described, EBV-1 and EBV-2. Whereas type 1 is known to be most widespread throughout the healthy adult population, type 2 EBV has been shown to be significantly present in certain T-cell immunocompromised patients. Some evidence also suggests that such...

Topics

Blotting, Southern
Blotting, Western
Electrophoresis, Agar Gel
Epstein-Barr Virus Nuclear Antigens
Genetic Variation
Genome, Viral
Herpesvirus 4, Human
Humans
Lymphoma
Polymerase Chain Reaction
Recombination, Genetic
Tumor Cells, Cultured
Virus Latency

Source

Open in PubMed

Identifiers

PMID: 10562498
DOI: 10.1006/viro.1999.0015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics